Dare Bioscience Inc (DARE) stock has gained 1.10% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary scoring system, gives DARE stock a score of 56 out of a possible 100.
That score is mainly influenced by a fundamental score of 84. In addition to the average rating from Wall Street analysts, DARE stock has a mean target price of $4.88. This means analysts expect the stock to gain 430.43% over the next 12 months. DARE’s score also includes a long-term technical score of 53. The short-term technical score for DARE is 30.
What’s Happening with DARE Stock Today
Dare Bioscience Inc (DARE) stock is higher by 11.23% while the S&P 500 is down -0.35% as of 11:29 AM on Monday, Nov 11. DARE has gained $0.09 from the previous closing price of $0.83 on volume of 6,987,897 shares. Over the past year the S&P 500 has risen 13.06% while DARE has gained 1.10%. DARE lost -$1.56 per share in the over the last 12 months.
